Astrazeneca - activities

Covid: Janssen vaccine to arrive in May, with one month delay

The Health Minister has announced Janssen Covid vaccine – aka Johnson & Johnson subsidiary – will arrive in France later than expected, in May 2021 instead of April. A vaccine still waiting to be approved by the European Medicines Agency.

Covid: vaccines effective from the first shot, a Scottish study finds

According to a wide study carried out in Scotland, Covid vaccines developed by Pfizer and AstraZeneca dramatically decrease risk of severe Covid from the first shot.

AstraZeneca vaccine now approved in France for people aged 65-74

After being recommended this past February 10 by WHO for people aged 65+, AstraZeneca vaccine has also been approved in France for people between the age of 65 and 75. This is what Olivier Véran announced on Monday March 1, 2021 on France 2, during an interview.

AstraZeneca vaccine: enhanced vigilance after adverse effects reported in 149 health workers

AstraZeneca vaccine subject to worries… This Thursday February 11, the ANSM said that in 10,000 health workers vaccinated, 149 of them developed mild but harsh side effects such as fever, headache and flu-like condition. Adverse effects required for some to call in sick.

Covid: AstraZeneca vaccine approved by France's Haute Autorité de Santé for people under 65

Appproved by the European Medicines Agency since this Friday January 29, Covid vaccine by AstraZeneca has been approved, this Tuesday February 2, by the Haute Autorité de Santé only for people under the age of 65. It is to arrive in France from February 8 - according to Secretary of State for European Affairs Clément Beaune.

Covid: AstraZeneca to deliver 30% extra doses in Europe for the first quarter of the year

This Sunday January 31, European Commission president Ursula Von der Leyen announces AstraZeneca will deliver 30% more vaccine doses than announced for the first quarter of 2021, namely 40 million doses more.

Coronavirus: Chinese Sinopharm vaccine’s effectiveness

As vaccine campaigns have started around the globe, Sinopharm unveils the effectiveness of their vaccine. It is the first Chinese laboratory to share these data.

Coronavirus: AstraZeneca says they have found a 100% safe safe formula against the virus

British pharmaceutical group AstraZeneca announced their vaccine provides a "winning formula" against severe forms of Covid-19.

AstraZeneca Covid vaccine “safe and effective” The Lancet says

Is AstraZeneca covid vaccine safe and effective against the virus as well? This is what seem to say results from the analysis published in medical journal The Lancet. Results have been peer-reviewed and the vaccine is said to be about 70% effective.

Covid: can you be contagious although vaccinated?

As the whole world is waiting for the vaccine that will put an end to the coronavirus epidemic, the French Haute Autorité de Santé expresses a doubt as to the ability of the vaccine to stop from spreading, even though it is effective.

Covid-19: Calquence, an effective treatment against cytokine shocks?

Is Claquence an effective treatment to fight against Covid-19? Pharmaceutical group AstraZeneca has announced phase 2 of their clinical trials with this potential treatment to coronavirus “did not meet the primary endpoint”. A clinical trial which point was to try and assess its effect against cytokine shocks, this violent inflammatory response from the immune system, combined with Covid-19 infection.

Coronavirus: a vaccine to be put into circulation from September 2020?

A race for vaccine that is getting harsher to wipe out coronavirus! AstraZeneca has announced they were able to provide 300 million doses of their vaccine from September 2020. The vaccine is put into circulation very quickly given clinical trials in humans have not delivered their first outcomes.

Coronavirus: France teams up with three other European countries to purchase vaccines

In order to fight against the Covid-19 pandemic as well as possible, France has teamed up with Germany, the Netherlands, and Italy within Europe’s Inclusive Vaccines Alliance. Together, they announce to have signed a first principle agreement with the AstraZeneca laboratory to buy several millions of vaccine doses.